The 2024 Multidisciplinary Head and Neck Cancers Symposium Steering Committee has reviewed and approved these symposia as appropriate for presentation as an Industry Satellite Symposia (ISS). The ISS constitutes the content and views of the sponsor and is not part of the official 2024 Multidisciplinary Head and Neck Cancers Symposium program.
Grand Canyon 3
6:00 p.m. - 7:30 p.m.: Dinner and Symposium
Recurrent/Metastatic HNSCC: Harnessing Immunotherapy in Comprehensive Care
Participate in the live session via Zoom.
Learning objectives
Target audience
The target audience of this activity includes oncologists, head and neck surgeons, nurse practitioners, physician assistants/associates, oncology nurses and other health care professionals involved in the treatment of patients with head and neck squamous cell carcinoma (HNSCC).
Program agenda
Description
Case studies will be used to foster interactive discussion regarding interdisciplinary strategies to optimize disease control, survival and quality of life in patients with recurrent/metastatic HNSCC. Featured cases will be selected based on their capacity to illustrate diagnostic pathways, the application of novel checkpoint inhibitors, approaches for detecting and managing symptoms and immune-related adverse events, and methods for supporting patients throughout the continuum of care.
*Faculty will select the actual patient cases.
Faculty
Glenn J. Hanna, MD
Director, Center for Cancer Therapeutic Innovation (Early Drug Development Program)
Medical Oncologist, Center for Head and Neck Oncology
Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Deborah Wong, MD, PhD
Associate Clinical Professor of Medicine
Division of Hematology-Oncology
UCLA Medical Center
Accreditation Statement
In support of improving patient care, i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit Designation Statement
i3 Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A maximum of 1.5 ANCC contact hours may be earned by learners who successfully complete this nursing continuing professional development activity.
This activity is supported by an independent educational grant from Merck Sharpe & Dohme LLC.
Grand Canyon 4-5
6:15 a.m. - 6:45 a.m.: Registration and Breakfast
6:45 a.m. - 7:55 a.m.: Symposium
OncoChallenge in Locally Advanced Head and Neck Cancer: Exploring New Directions
Participate in the live session via Medscape's virtual stream.
Event description
Join us in Phoenix for a lively quiz show-style symposium on locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). During this interactive activity, experts will review the optimal management of LA SCCHN, from diagnosis and pathophysiology to multidisciplinary management strategies, including promising novel agents. Don’t miss this opportunity to interact with the experts!
Learning objectives
Upon completion of this activity, learners will have:
Increased knowledge regarding the:
Greater competence related to:
Greater confidence in their ability to incorporate the patient voice in the interdisciplinary care of LA SCCHN.
Target audience
The target audience for this program is oncologists, radiation oncologists, head and neck surgeons, nurses, pharmacists and other professionals involved in the care of patients with locally advanced squamous cell carcinoma of the head and neck.
Faculty
Robert Ferris, MD, PhD – Moderator
Director, UPMC Hillman Cancer Center
Hillman Professor of Oncology
UPMC Senior Vice President for Oncology Programs
Associate Vice-Chancellor for Cancer Research
University of Pittsburgh School of Medicine
Pittsburgh
Nancy Lee, MD, FASTRO – Panelist
Vice Chair, Experimental Therapeutics
Department of Radiation Oncology
Service Chief, Head and Neck Radiation Oncology
Service Chief, Proton Therapy
Memorial Sloan Kettering Cancer Center
New York
Nabil Saba, MD, FACP – Panelist
Professor and Vice Chair, Hematology and Medical Oncology
The Lynne and Howard Halpern Chair in Head and Neck Cancer Research
Director, Head and Neck Oncology
Co-Director Head and Neck CA Multidisciplinary Program
Winship Cancer Institute
Emory University
Atlanta
Accreditation Statement
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit Designation
For Physicians
Medscape, LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For Nurses
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs.
For Pharmacists
Medscape designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs).
IPCE
1.25 Interprofessional Continuing Education (IPCE) credit
This activity was planned by and for the health care team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an independent educational grant from EMD Serono.
